He turned to his computer and pulled up the stock market data once again. As expected, the pharmaceutical companies backing the serum were skyrocketing in value. Investors were flocking to them like moths to a flame. The trend was clear: anyone not aligning themselves with this new development would be left in the dust. Morality, ethics, and caution—these things were being thrown aside in the rush to be part of the next big thing.
For Fox Labs, this posed a serious problem. Without the backing of the larger pharmaceutical industry or the media, their own advancements in life-force research would be overshadowed. Worse, even potential collaborators might be drawn away, lured by the promise of faster returns and higher profits.
Martin clenched his fist, frustration bubbling up inside him.
